机器人对比传统或内镜辅助保留乳头乳房切除术联合即刻假体乳房重建的多中心前瞻性研究
该前瞻性三臂非随机多中心试验比较机器人辅助、内镜辅助与传统保留乳头乳房切除术联合即刻假体乳房重建的临床结局、医疗费用及患者报告结局。共纳入73例机器人、74例传统和84例内镜手术,微创组伤口愈合更优、伤口相关满意度更高,但机器人手术费用显著高于传统和内镜手术,三组并发症及初步肿瘤学结果无差异。
要点
- 微创保留乳头乳房切除术较传统手术伤口愈合更优且伤口相关满意度更高。
- 机器人手术费用分别比传统和内镜手术高4000和2600美元。
- 三组并发症及初步肿瘤学结果无显著差异。
核心结论
- 机器人或内镜辅助保留乳头乳房切除术在围手术期并发症方面是传统手术的安全替代方案,尤其伤口愈合更优。
- 微创组的优势在于更高的伤口相关满意度。
- 机器人手术的较高费用仍是其广泛推广的主要限制因素之一。
研究设计与样本
- 共纳入73例机器人辅助、74例传统和84例内镜辅助保留乳头乳房切除术联合即刻假体乳房重建。
主要发现
- 中位伤口长度和手术时间:传统组为9 cm和175分钟,机器人组为4 cm和195分钟,内镜组为4 cm和222分钟。
- 三组并发症相当,微创组伤口愈合更优。
- 机器人手术费用分别比传统和内镜手术高4000和2600美元。
- 伤口/瘢痕和术后急性疼痛评估支持微创保留乳头乳房切除术优于传统手术。
- 慢性乳房/胸部疼痛、活动能力和上肢活动范围方面的生活质量无显著差异。
临床怎么用
- 对于适合保留乳头乳房切除术的患者,可考虑机器人或内镜辅助微创手术以改善伤口愈合和伤口相关满意度。
- 选择机器人手术时需权衡其较高的医疗费用。
局限性
- 为非随机试验设计。
- 肿瘤学结果为初步结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the clinical and patient-reported outcomes of minimal access and conventional nipple-sparing mastectomy (C-NSM). The secondary outcomes investigated included medical costs and oncological safety. BACKGROUND: Minimal-access NSM has been increasingly applied in the treatment of patients with breast cancer. However, prospective multicenter trials comparing robotic-assisted NSM (R-NSM) versus C-NSM or endoscopic-assisted NSM (E-NSM) are lacking. METHODS: A prospectively designed 3-arm multicenter, nonrandomized trial (NCT04037852) was conducted from October 1, 2019 to December 31, 2021, to compare R-NSM with C-NSM or E-NSM. RESULTS: A total of 73 R-NSM, 74 C-NSM, and 84 E-NSM procedures were enrolled. The median wound length and operation time of C-NSM was (9 cm, 175 minutes), (4 cm, and 195 minutes) in R-NSM, and (4 cm and 222 minutes) in E-NSM. Complications were comparable among the groups. Better wound healing was observed in the minimal-access NSM group. The R-NSM procedure was 4000 and 2600 United States Dollars more expensive than C-NSM and E-NSM, respectively. Wound/scar and postoperative acute pain evaluation favored the use of minimal access NSM over C-NSM. Quality of life in terms of chronic breast/chest pain, mobility, and range of motion of the upper extremity showed no significant differences. The preliminary oncologic results showed no differences among the 3 groups. CONCLUSIONS: R-NSM or E-NSM is a safe alternative if compared with C-NSM in terms of perioperative morbidities, especially with better wound healing. The advantage of minimal access groups was higher wound-related satisfaction. Higher costs remain one of the major limiting factors in the widespread adoption of R-NSM.
引用
- Lai HW, Chen DR, Liu LC, et al. Robotic Versus Conventional or Endoscopic-assisted Nipple-sparing Mastectomy and Immediate Prosthesis Breast Reconstruction in the Management of Breast Cancer: A Prospectively Designed Multicenter Trial Comparing Clinical Outcomes, Medical Cost, and Patient-reported Outcomes (RCENSM-P). Ann Surg. 2023. PMID: 37226826. doi:10.1097/SLA.0000000000005924
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。